Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 97

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing

Saber Sichani, Ali, Ranjbar, Maryam, Baneshi, Maryam, Torabi Zadeh, Farid, Fallahi, Jafar · 2023 · Molecular Biotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12033-022-00639-1

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 62

  1. Gallagher, D. N., & Haber, J. E. (2018). Repair of a site-specific DNA cleavage: Old-school lessons for Cas9-mediated gene editing. ACS Chemical Biology, 13(2), 397–405. · DOI
  2. Rouet, P., Smih, F., & Jasin, M. (1994). Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Molecular and Cellular Biology, 14(12), 8096–8106.
  3. Mao, Z., Bozzella, M., Seluanov, A., & Gorbunova, V. (2008). Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair, 7(10), 1765–1771. · DOI · Paper page
  4. Song, F., & Stieger, K. (2017). Optimizing the DNA donor template for homology-directed repair of double-strand breaks. Molecular Therapy-Nucleic Acids, 7, 53–60. · DOI
  5. Bollen, Y., Post, J., Koo, B. K., & Snippert, H. J. (2018). How to create state-of-the-art genetic model systems: Strategies for optimal CRISPR-mediated genome editing. Nucleic Acids Research, 46(13), 6435–6454. · DOI
  6. Komor, A. C., Badran, A. H., & Liu, D. R. (2017). CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell, 168(1–2), 20–36. · DOI · Paper page
  7. Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., & Raguram, A. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576(7785), 149–157. · DOI · Paper page
  8. Wang, D., Zhang, F., & Gao, G. (2020). CRISPR-based therapeutic genome editing: Strategies and in vivo delivery by AAV vectors. Cell, 181(1), 136–150. · DOI · Paper page
  9. Thurtle-Schmidt, D. M. (2018). Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates. Biochemistry and Molecular Biology Education, 46(2), 195–205. · DOI · Paper page
  10. Li, Q., Qin, Z., Wang, Q., Xu, T., Yang, Y., & He, Z. (2019). Applications of genome editing technology in animal disease modeling and gene therapy. Computational and Structural Biotechnology Journal, 17, 689–698. · DOI
  11. Khan, S. H. (2019). Genome-editing technologies: Concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. Molecular Therapy-Nucleic Acids, 16, 326–334. · DOI · Paper page
  12. Aubert, M., Strongin, D. E., Roychoudhury, P., Loprieno, M. A., Haick, A. K., Klouser, L. M., Stensland, L., Huang, M.-L., Makhsous, N., & Tait, A. (2020). Gene editing and elimination of latent herpes simplex virus in vivo. Nature Communications, 11(1), 1–15. · DOI
  13. LaFountaine, J. S., Fathe, K., & Smyth, H. D. (2015). Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9. International Journal of Pharmaceutics, 494(1), 180–194. · DOI · Paper page
  14. Benjamin, R., Berges, B. K., Solis-Leal, A., Igbinedion, O., Strong, C. L., & Schiller, M. R. (2016). TALEN gene editing takes aim on HIV. Human Genetics, 135(9), 1059–1070. · DOI
  15. Janik, E., Niemcewicz, M., Ceremuga, M., Krzowski, L., Saluk-Bijak, J., & Bijak, M. (2020). Various aspects of a gene editing system—crispr–cas9. International Journal of Molecular Sciences, 21(24), 9604. · DOI · Paper page
  16. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821. · DOI · Paper page
  17. Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987). Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169(12), 5429–5433. · DOI · Paper page
  18. Khalil, A. M. (2020). The genome editing revolution. Journal of Genetic Engineering and Biotechnology, 18(1), 1–16. · DOI · Paper page
  19. Wu, W. Y., Lebbink, J. H., Kanaar, R., Geijsen, N., & Van Der Oost, J. (2018). Genome editing by natural and engineered CRISPR-associated nucleases. Nature Chemical Biology, 14(7), 642–651. · DOI
  20. Baghini, S. S., Gardanova, Z. R., Zekiy, A. O., Shomali, N., Tosan, F., & Jarahian, M. (2021). Optimizing sgRNA to improve CRISPR/Cas9 knockout efficiency: Special focus on human and animal cell. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2021.775309 · DOI
  21. Uniyal, A. P., Mansotra, K., Yadav, S. K., & Kumar, V. (2019). An overview of designing and selection of sgRNAs for precise genome editing by the CRISPR-Cas9 system in plants. 3Biotech, 9(6), 1–19.
  22. Liu, P., Liang, S.-Q., Zheng, C., Mintzer, E., Zhao, Y. G., Ponnienselvan, K., Mir, A., Sontheimer, E. J., Gao, G., & Flotte, T. R. (2021). Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nature Communications, 12(1), 1–13. · DOI · Paper page
  23. Liu, R., Liang, L., Freed, E. F., & Gill, R. T. (2021). Directed evolution of CRISPR/Cas systems for precise gene editing. Trends in Biotechnology, 39(3), 262–273. · DOI
  24. Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., Van Der Oost, J., & Regev, A. (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163(3), 759–771. · DOI · Paper page
  25. Bandyopadhyay, A., Kancharla, N., Javalkote, V. S., Dasgupta, S., & Brutnell, T. P. (2020). CRISPR-Cas12a (Cpf1): A versatile tool in the plant genome editing tool box for agricultural advancement. Frontiers in Plant Science, 11, 1589. · DOI · Paper page
  26. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., & Marraffini, L. A. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science, 339(6121), 819–823. · DOI · Paper page
  27. Berber, B., Aydin, C., Kocabas, F., Guney-Esken, G., Yilancioglu, K., Karadag-Alpaslan, M., Caliseki, M., Yuce, M., Demir, S., & Tastan, C. (2021). Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics. Gene Therapy, 28(6), 290–305. · DOI
  28. Rautela, I., Uniyal, P., Thapliyal, P., Chauhan, N., Sinha, V. B., & Sharma, M. D. (2021). An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications. Gene, 785, 145615. · DOI
  29. Eid, A., Alshareef, S., & Mahfouz, M. M. (2018). CRISPR base editors: Genome editing without double-stranded breaks. Biochemical Journal, 475(11), 1955–1964. · DOI · Paper page
  30. Molla, K. A., & Yang, Y. (2019). CRISPR/Cas-mediated base editing: Technical considerations and practical applications. Trends in Biotechnology, 37(10), 1121–1142. · DOI · Paper page
  31. Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: Advances and therapeutic opportunities. Nature Reviews Drug Discovery, 19(12), 839–859. · DOI · Paper page
  32. Kim, J.-S. (2018). Precision genome engineering through adenine and cytosine base editing. Nature Plants, 4(3), 148–151. · DOI
  33. Evanoff, M., & Komor, A. C. (2019). Base editors: Modular tools for the introduction of point mutations in living cells. Emerging Topics in Life Sciences, 3(5), 483–491. · DOI
  34. Kantor, A., McClements, M. E., & MacLaren, R. E. (2020). CRISPR-Cas9 DNA base-editing and prime-editing. International Journal of Molecular Sciences, 21(17), 6240. · DOI · Paper page
  35. Rees, H. A., & Liu, D. R. (2018). Base editing: Precision chemistry on the genome and transcriptome of living cells. Nature Reviews Genetics, 19(12), 770–788. · DOI · Paper page
  36. Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J.-L., Wang, D., & Gao, C. (2017). Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion. Nature Biotechnology, 35(5), 438–440. · DOI · Paper page
  37. Li, J., Sun, Y., Du, J., Zhao, Y., & Xia, L. (2017). Generation of targeted point mutations in rice by a modified CRISPR/Cas9 system. Molecular Plant, 10(3), 526–529. · DOI · Paper page
  38. Liang, P., Ding, C., Sun, H., Xie, X., Xu, Y., Zhang, X., Sun, Y., Xiong, Y., Ma, W., & Liu, Y. (2017). Correction of β-thalassemia mutant by base editor in human embryos. Protein & Cell, 8(11), 811–822. · DOI · Paper page
  39. Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018). Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nature Biotechnology, 36(9), 843–846. · DOI · Paper page
  40. Musunuru, K., & Kathiresan, S. (2017). Is ANGPTL3 the next PCSK9? Nature Reviews Endocrinology, 13(9), 503–504. · DOI
  41. Zeng, Y., Li, J., Li, G., Huang, S., Yu, W., Zhang, Y., Chen, D., Chen, J., Liu, J., & Huang, X. (2018). Correction of the Marfan syndrome pathogenic FBN1 mutation by base editing in human cells and heterozygous embryos. Molecular Therapy, 26(11), 2631–2637. · DOI
  42. Li, X., Qian, X., Wang, B., Xia, Y., Zheng, Y., Du, L., Xu, D., Xing, D., DePinho, R. A., & Lu, Z. (2020). Programmable base editing of mutated TERT promoter inhibits brain tumour growth. Nature Cell Biology, 22(3), 282–288. · DOI
  43. Lin, X., Chen, H., Lu, Y.-Q., Hong, S., Hu, X., Gao, Y., Lai, L.-L., Li, J.-J., Wang, Z., & Ying, W. (2020). Base editing-mediated splicing correction therapy for spinal muscular atrophy. Cell Research, 30(6), 548–550. · DOI
  44. Levy, J. M., Yeh, W.-H., Pendse, N., Davis, J. R., Hennessey, E., Butcher, R., Koblan, L. W., Comander, J., Liu, Q., & Liu, D. R. (2020). Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nature Biomedical Engineering, 4(1), 97–110. · DOI · Paper page
  45. Gaudelli, N. M., Lam, D. K., Rees, H. A., Solá-Esteves, N. M., Barrera, L. A., Born, D. A., Edwards, A., Gehrke, J. M., Lee, S.-J., & Liquori, A. J. (2020). Directed evolution of adenine base editors with increased activity and therapeutic application. Nature Biotechnology, 38(7), 892–900. · DOI · Paper page
  46. Wu, F., Guo, T., Sun, L., Li, F., & Yang, X. (2022). Base editing of human pluripotent stem cells for modeling long QT syndrome. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-021-10324-6 · DOI
  47. Rosello, M., Serafini, M., Mignani, L., Finazzi, D., Giovannangeli, C., Mione, M. C., Concordet, J.-P., & Del Bene, F. (2022). Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications, 13(1), 1–13. · DOI
  48. Huang, S., Zhang, Z., Tao, W., Liu, Y., Li, X., Wang, X., Harati, J., Wang, P.-Y., Huang, X., & Lin, C.-P. (2022). Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA. Molecular Therapy, 30(9), 2923–2932. · DOI
  49. Huang, X., Wang, Y., & Wang, N. (2022). Base editors for citrus gene editing. Frontiers in Genome Editing. https://doi.org/10.3389/fgeed.2022.852867 · DOI
  50. Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013). RNA-guided human genome engineering via Cas9. Science, 339(6121), 823–826. · DOI · Paper page
  51. Bosch, J. A., Birchak, G., & Perrimon, N. (2021). Precise genome engineering in Drosophila using prime editing. Proceedings of the National Academy of Sciences, 118(1), e2021996118. · DOI
  52. Liu, Y., Li, X., He, S., Huang, S., Li, C., Chen, Y., Liu, Z., Huang, X., & Wang, X. (2020). Efficient generation of mouse models with the prime editing system. Cell Discovery, 6(1), 1–4. · DOI · Paper page
  53. Sürün, D., Schneider, A., Mircetic, J., Neumann, K., Lansing, F., Paszkowski-Rogacz, M., Hänchen, V., Lee-Kirsch, M. A., & Buchholz, F. (2020). Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors. Genes, 11(5), 511. · DOI
  54. Schene, I. F., Joore, I. P., Oka, R., Mokry, M., van Vugt, A. H., van Boxtel, R., van der Doef, H. P., van der Laan, L. J., Verstegen, M., & van Hasselt, P. M. (2020). Prime editing for functional repair in patient-derived disease models. Nature Communications, 11(1), 1–8. · DOI · Paper page
  55. Anzalone, A. V., Gao, X. D., Podracky, C. J., Nelson, A. T., Koblan, L. W., Raguram, A., Levy, J. M., Mercer, J. A., & Liu, D. R. (2022). Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nature Biotechnology, 40(5), 731–740. · DOI · Paper page
  56. Ferreira da Silva, J., Oliveira, G. P., Arasa-Verge, E. A., Kagiou, C., Moretton, A., Timelthaler, G., Jiricny, J., & Loizou, J. I. (2022). Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. Nature Communications, 13(1), 1–11. · DOI · Paper page
  57. Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J., & Marra, G. (2002). Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology, 122(1), 211–219. · DOI · Paper page
  58. Gupta, S., Gellert, M., & Yang, W. (2012). Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops. Nature Structural & Molecular Biology, 19(1), 72–78. · DOI · Paper page
  59. Koeppel, J., Peets, E. M., Weller, J., Pallaseni, A., Liberante, F., & Parts, L. (2021). Predicting efficiency of writing short sequences into the genome using prime editing. bioRxiv. https://doi.org/10.1101/2021.11.10.468024 · DOI
  60. Chen, P. J., Hussmann, J. A., Yan, J., Knipping, F., Ravisankar, P., Chen, P. F., Chen, C., Nelson, J. W., Newby, G. A., & Sahin, M. (2021). Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell, 184(22), 5635-5652.e5629. · DOI · Paper page
  61. Hsu, J. Y., Grünewald, J., Szalay, R., Shih, J., Anzalone, A. V., Lam, K. C., Shen, M. W., Petri, K., Liu, D. R., & Joung, J. K. (2021). PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nature Communications, 12(1), 1–6. · DOI · Paper page
  62. Nelson, J. W., Randolph, P. B., Shen, S. P., Everette, K. A., Chen, P. J., Anzalone, A. V., An, M., Newby, G. A., Chen, J. C., & Hsu, A. (2022). Engineered pegRNAs improve prime editing efficiency. Nature Biotechnology, 40(3), 402–410. · DOI · Paper page

Cited by

See all 97

Metadata

Authors
Saber Sichani, A., Ranjbar, M., Baneshi, M., Torabi Zadeh, F., & Fallahi, J.
Venue
Molecular Biotechnology
Published
2022-12-22
Volume
65
Issue
6
Pages
849-860
ISSN
  • 1073-6085
  • 1559-0305
Cited by
97
References
22
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing. https://app.cochat.ai/papers/10.1007/s12033-022-00639-1
The paper
Saber Sichani, A., Ranjbar, M., Baneshi, M., Torabi Zadeh, F., & Fallahi, J. (2023). A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing. Molecular Biotechnology. https://doi.org/10.1007/s12033-022-00639-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.